Related Experiment Video

Updated: Apr 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

To target or not to target viral antigens in HBV related HCC?

Sonja I Buschow1, Dave Sprengers1, Andrea M Woltman1

  • 1Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Journal of Hepatology
|February 26, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.5K

Related Experiment Videos

Last Updated: Apr 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.5K

Related Concept Videos

Hepatitis01:25

Hepatitis

63
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63

Articles linked to this work by shared authors, journal, and citation graph.

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026

Beyond a single ideal: An appreciative inquiry into students' perspectives on workplace-based assessment during clerkships.

Medical education·2026

Selective internal radiotherapy vs transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic review.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026

Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort.

JHEP reports : innovation in hepatology·2026

The effect of feedback on the diagnostic process of physicians at the emergency department: a systematic review.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine·2026

Clinical Utility and Diagnostic Accuracy of the GAAD Score in Non-cirrhotic Patients With Focal Liver Lesions.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Systemic therapy for HCC: Doublets, triplets and beyond.

Journal of hepatology·2026

Integrating systemic therapy in the earlier stages of liver cancer.

Journal of hepatology·2026

The use of locoregional therapies in cholangiocarcinoma.

Journal of hepatology·2026

Liver transplantation for primary liver cancers in the era of transplant oncology.

Journal of hepatology·2026

Advances in the imaging of liver cancer.

Journal of hepatology·2026

Mouse models of acute and chronic hepatitis E virus infection.

Journal of hepatology·2026

Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.

European journal of neurology·2026

Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Prognostic value of the HALP (hemoglobin, albumin, lymphocyte, and platelet) score in emergency versus elective inguinal hernia repair: A retrospective study.

Medicine·2026

Comparing Three Scoring Models for Predicting Unruptured Intracranial Aneurysm Progression in Subarachnoid Hemorrhage Patients with Multiple Intracranial Aneurysms.

Academic radiology·2026

Association of time of day at stroke onset with functional outcomes after reperfusion therapy in acute ischaemic stroke: a retrospective cohort study in China.

BMJ open·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us